This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
SCHW vs. TW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SCHW vs. TW: Which Stock Is the Better Value Option?
Interactive Brokers (IBKR) Stock Declines on Q1 Earnings Miss
by Zacks Equity Research
Interactive Brokers (IBKR) records a y/y fall in revenues and expenses in the first quarter of 2022.
Company News for Apr 19, 2022
by Zacks Equity Research
Companies In The News Are: TWTR, SCHW, SYF, DIDI
Big Week Ahead in Q1 Earnings, Econ Data
by Mark Vickery
Pre-market futures are down a bit to start the week: this follows two straight down weeks for the S&P 500 and Nasdaq, and three straight on the Dow.
Schwab (SCHW) Down as Q1 Earnings Miss Estimates, Costs Rise
by Zacks Equity Research
Fall in revenues and higher expenses hurt Schwab's (SCHW) Q1 earnings. The dismal performance weighs on investor sentiments.
The Charles Schwab Corporation (SCHW) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
The Charles Schwab Corporation (SCHW) delivered earnings and revenue surprises of -9.41% and 3.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Q1 Earnings To Gather Pace This Week
by Zacks Equity Research
Q1 Earnings To Gather Pace This Week.
The Charles Schwab Corporation (SCHW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, The Charles Schwab Corporation (SCHW) closed at $82.75, marking a -1.29% move from the previous day.
Morgan Stanley (MS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Morgan Stanley (MS) delivered earnings and revenue surprises of 21.89% and 5.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Positive Earnings Surprise Likely for Schwab (SCHW) in Q1?
by Zacks Equity Research
Despite a rise in volatility, Schwab (SCHW) is not expected to have witnessed much growth in first-quarter 2022 trading revenues due to relatively lower client activity.
The Zacks Analyst Blog Highlights Pfizer, Charles Schwab, Vale, Citigroup, and Palo Alto Networks
by Zacks Equity Research
Pfizer, Charles Schwab, Vale, Citigroup, and Palo Alto Networks are part of the Top Analyst Blog.
Top Stock Reports for Pfizer, Charles Schwab & Vale
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), The Charles Schwab Corporation (SCHW), and Vale S.A. (VALE).
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Charles Schwab Corporation (SCHW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The Charles Schwab Corporation (SCHW) closed the most recent trading day at $80.03, moving -1.04% from the previous trading session.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Chevron and Big Lots have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Chevron and Big Lots are part of Today's Bull and Bear of the Day article.
Interactive Brokers (IBKR) Records a Decline in March DARTs
by Zacks Equity Research
Interactive Brokers (IBKR) reports a decline in client DARTs number for March 2022.
The Charles Schwab Corporation (SCHW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, The Charles Schwab Corporation (SCHW) closed at $83.54, marking a -0.91% move from the previous day.
The Zacks Analyst Blog Highlights Alphabet, Abbott Laboratories, The Charles Schwab, Canadian National Railway Company and Air Products and Chemicals
by Zacks Equity Research
Alphabet, Abbott Laboratories, The Charles Schwab, Canadian National Railway Company and Air Products and Chemicals have been included in this Analyst Blog.
Top Research Reports for Alphabet, Abbott, & Charles Schwab
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Abbott Laboratories (ABT) and The Charles Schwab Corporation (SCHW).
The Charles Schwab Corporation (SCHW) Gains But Lags Market: What You Should Know
by Zacks Equity Research
The Charles Schwab Corporation (SCHW) closed at $90.93 in the latest trading session, marking a +1.31% move from the prior day.
The Charles Schwab Corporation (SCHW) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
The Charles Schwab Corporation (SCHW) closed at $89.01 in the latest trading session, marking a -1.1% move from the prior day.
LPL Financial (LPLA) February Metrics Down on Adverse Markets
by Zacks Equity Research
Unfavorable markets hurt LPL Financial's (LPLA) total brokerage and advisory assets balance in February.
The Charles Schwab Corporation (SCHW) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The Charles Schwab Corporation (SCHW) closed the most recent trading day at $83.17, moving -0.11% from the previous trading session.
Schwab (SCHW) February Client Assets Fall Q/Q on Markets Woes
by Zacks Equity Research
Unfavorable markets hurt Schwab's (SCHW) total client assets balance in February. Yet, solid core asset balance is expected to keep supporting its top-line growth.